A European patient registry study of Melphalan in the treatment of multiple tumor types

Trial Profile

A European patient registry study of Melphalan in the treatment of multiple tumor types

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Oct 2016

At a glance

  • Drugs Melphalan (Primary)
  • Indications Cancer; Uveal melanoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 Oct 2016 According to a Delcath Systems media release, data from the study will be used as supportive evidence in our global Health Authority submissions.
    • 30 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top